News
Appointment of VP, Global Markets
09 July 2007
TyraTech (AIM:TYR), the pioneer of safer, effective and natural pesticide products, announced today the appointment of Stephen P. Briggs as Vice President Global Markets with immediate effect. In this senior management role, Mr Briggs will lead the sales and marketing organisation and the strategic development of markets for TyraTech’s new class of highly effective, non-toxic, insecticides and anti-parasitics.
Mr Briggs brings to TyraTech 26 years’ experience working in agricultural crop protection and speciality pesticide market products. He has a proven track record of increasing company sales and profitability in his previous positions at American Cyanamid Co., Micro Flo Company and most recently, BASF Corp.
Prior to joining the Company he was Director of the Specialty Products Department, which markets products and services into the Pest Control market, the Vegetation Control market and the Turf and Ornamental marketplace at BASF Corp, one of the world’s leading chemical pesticide companies, leading the restructuring of the North American business and substantially increasing its revenue.
As the past Chairman of the Responsible Industry for a Sound Environment Board (“RISE”), Mr Briggs is widely recognised within the pesticide industry sector. RISE is a US not-for-profit trade association representing producers and suppliers of specialty pesticides and fertilizers, which serves as a resource and advocate for member companies, providing current and accurate information on issues and research affecting the industry. The association also monitors legislative and regulatory issues in the United States.
Douglas Armstrong PhD, Chief Executive Officer of TyraTech, said: “Steve Briggs is a very important addition to our senior management team. His wealth of knowledge and expertise in the global commercial exploitation of insecticide and agricultural products combined with considerable and widely respected leadership and management skills, will strengthen our Company.”
For further information
| TyraTech Inc. Alan Reade, Executive Chairman www.tyratech.com |
1 (321) 409 - 7720 |
| Nomura Code Securities | |
| Charles Walker | Tel: +44 (0) 20 7776 1200 |
| www.nomuracode.com |
Media enquiries:
Abchurch |
|
| Heather Salmond | Tel: +44 (0) 20 7398 7700 |
| heather.salmond@abchurch-group.com | |
| Gareth Mead | |
| gareth.mead@abchurch-group.com | |
| Stephanie Cuthbert | |
| stephanie.cuthbert@abchurch-group.com | www.abchurch-group.com |
About TyraTech, Inc.
TyraTech is pioneering a new class of highly effective, non-toxic, pesticides and anti-parasitic compounds to address global agriculture, horticulture, functional foods, healthcare and veterinary markets. Using a revolutionary chemoreceptor screening process, TyraTech has identified proprietary blends of natural oils that stimulate the reactions and biological behaviour of insects and parasites so that they can be effectively repelled or killed. TyraTech’s technology prevents the development of resistance and avoids the environmental concerns and human health risks of chemical solutions whilst still being at least, if not more, effective.
The Company’s products have been validated through strong partnerships with multinational conglomerates operating within a growing US$23 billion worldwide market that is being increasingly driven by environmental legislation and end-user demand.
TyraTech continues to develop new product applications based on safe, natural ingredients with a broad range of partners around the world.
“Some of the information contained in this press release contains forward-looking statements. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are, by their nature, subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. We caution you not to rely on any such statements as statements of historical fact or as guarantees or assurances of future performance. We undertake no obligation to publicly update or revise and forward-looking statements.”
This press release does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any Common Shares of the Company or any other securities, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefore. This document is not a prospectus and no person should subscribe for or purchase any shares referred to in this document except on the basis of the information in the Prospectus.
The Common Shares have not been registered under the Securities Act of 1933, as amended, or any state securities laws and may be offered and sold only in transactions exempt from, or not subject to, the registration requirements of such Act.
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.